Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you're an employee looking for your AccessHope benefit, call 844‑222‑4673 or schedule an appointment to speak with your cancer support team.

AccessHope Joins Collective Health's Premier Partner Program

07/20/21 - Collective Health

AccessHope has joined Collective Health's Premier Partner Program™. The program helps employers navigate the complex digital landscape to easily select, integrate, and evaluate digital health partners for their 2022 benefits offering. While exploring the curated set of partners, they'll also gain deep insights on how to select the right solutions.

Read more

Cancer Benefits and Early Detection

06/22/21 - HR Works Podcast by HR Daily Advisor

AccessHope's CEO Mark Stadler was featured on HR Daily Advisor’s HR Works podcast, where he discusses the importance of early cancer detection. During the episode, Mark dives into opportunities for employers to provide cancer-specific benefits that help enhance healthcare, patient experiences, and the value of cancer care for their employees nationwide.

Read more

Prioritizing health and well-being will serve as a competitive ...

06/10/21 - Personalization Outbreak Podcast

AccessHope’s Chair of the Board Dr. Harlan Levine recently appeared on the Personalization Outbreak podcast to share information on AccessHope’s cancer support services. During the episode, Dr. Levine talks with its host, Glenn Llopis, about how AccessHope is working to extend access for employer plan members and their local oncologists to leading cancer expertise, closing the cancer knowledge gap while leveling cancer health disparities across the country.

Read more

Democratizing access to cancer care with AccessHope

06/03/21 - Willis Towers Watson's Cure for the Common Co. Podcast

AccessHope's Chair of the Board Dr. Harlan Levine recently appeared as a guest on Willis Towers Watson’s Cure for the Common Co. podcast series. In this series that features industry leaders who are changing the way healthcare and employee benefits are delivered, Dr. Levine shares with Willis Towers Watson's Senior Director of Health and Benefits Steve Blumenfield and North America and Benefits Strategic Growth Leader Ron Fontanetta how AccessHope's remote model brings preeminent cancer expertise and outcomes to our members while addressing cancer health disparities.

Read more

Telehealth best practices: How to best care for your patients when ...

05/20/21 - Authority Magazine

AccessHope’s CMO Dr. Todd Sachs recently spoke with Authority Magazine about his background in healthcare and lessons he has learned throughout his career. In the interview, he articulates the benefits of in-person visits while discussing the challenges of virtual visits for patients, and then based on his experience, shares ways physicians can make the most of remote healthcare, especially for those living with cancer.

Read more

Robert Stone: City of Hope aims to transform cancer care nationally ...

04/02/21 - The Cancer Letter

AccessHope offers a new model that remotely connects more people with cancer through their employer health benefits to world-class cancer support from the leading institutions City of Hope and Northwestern Medicine. By engaging these employees’ local healthcare providers into collaborative relationships, AccessHope is extending the reach of leading cancer expertise to elevate local cancer care, creating a system that increases patient access to potentially lifesaving support.

Read more

Supporting Your Employees Facing Cancer

02/03/21 - WorldatWork

AccessHope CEO Mark Stadler shares how employer demand is accelerating the need for innovative cancer support services, driven by the goals to spend healthcare dollars wisely and ensure the best possible outcomes and quality of life for employees navigating a cancer journey. 

Read more

Ruxolitinib for the Treatment of Steroid-Refractory Chronic ...

01/27/21 - JAMA Network Open

AccessHope’s Vice President and Executive Clinical Director Joseph Alvarnas, MD, published a study in JAMA Network Open highlighting the use of a new treatment for the potentially life-ending chronic graft-vs-host disease (cGVHD) resulting from allogeneic hematopoietic stem cell transplantation (HSCT).

Read more

Next

Get started with AccessHope today

AccessHope’s team of specialists is ready to help plan the best suite of cancer support services for your employees.

Get started

Dana-Farber Cancer Institute joins AccessHope to extend nationwide access to renowned cancer expertise.

Read Press Release